Evidence map›Paper›PMID 15447677›Full record

ArticleJournal of neurochemistry2004

Proteomic analysis of native metabotropic glutamate receptor 5 protein complexes reveals novel molecular constituents.

Carol D Farr, Philip R Gafken, Angela D Norbeck, Catalin E Doneanu, Martha D Stapels, Douglas F Barofsky, Manabu Minami, Julie A Saugstad

Open access · greenAbstract read
In one paragraph

Article in Journal of neurochemistry, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Carol D FarrRobert S. Dow Neurobiology Laboratories, Legacy Research, Portland, Oregon 97232, USA.
Philip R Gafken
Angela D Norbeck
Catalin E Doneanu
Martha D Stapels
Douglas F Barofsky
Manabu Minami
Julie A Saugstad
Legacy Health · USFred Hutch Cancer Center · USOregon State University · USUniversity of Washington · US

Funding

Reducing Susceptibility to Environmental Stress Throughout the Life SpanP30ES000210 · NIEHS · OREGON STATE UNIVERSITY · PI BECKMAN, JOSEPH S · 1985 to 2015
$21.4M
Extracellular Modulation of Metabotropic GluRsR21MH066967 · NIMH · EMANUEL HOSPITAL AND HEALTH CENTER · PI SAUGSTAD, JULIE ANNE · 2004 to 2005
$295k
NIEHS NIH HHS P30 ES000210NIEHS NIH HHS P30 ES00210NIMH NIH HHS R21 MH066967PHS HHS R01-521635
6 · The paper itself

Abstract

We used a proteomic approach to identify novel proteins that may regulate metabotropic glutamate receptor 5 (mGluR5) responses by direct or indirect protein interactions. This approach does not rely on the heterologous expression of proteins and offers the advantage of identifying protein interactions in a native environment. The mGluR5 protein was immunoprecipitated from rat brain lysates; co-immunoprecipitating proteins were analyzed by mass spectrometry and identified peptides were matched to protein databases to determine the correlating parent proteins. This proteomic approach revealed the interaction of mGluR5 with known regulatory proteins, as well as novel proteins that reflect previously unidentified molecular constituents of the mGluR5-signaling complex. Immunoblot analysis confirmed the interaction of high confidence proteins, such as phosphofurin acidic cluster sorting protein 1, microtubule-associated protein 2a and dynamin 1, as mGluR5-interacting proteins. These studies show that a proteomic approach can be used to identify candidate interacting proteins. This approach may be particularly useful for neurobiology applications where distinct protein interactions within a signaling complex can dramatically alter the outcome of the response to neurotransmitter release, or the disruption of normal protein interactions can lead to severe neurological and psychiatric disorders.

Indexed as

AlgorithmsAnimalsBrain ChemistryChromatography, LiquidComputational BiologyDatabases, ProteinElectrophoresisImmunoblottingMacromolecular SubstancesMaleMass SpectrometryPrecipitin TestsProtein BindingProteomicsRatsRats, Sprague-DawleyGrm5 protein, ratMacromolecular SubstancesReceptor, Metabotropic Glutamate 5Receptors, Metabotropic Glutamate

Identifiers

PMID15447677
PMCPMC2747775
OpenAlexW2082276312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.